Full Access
Manai of Vitiligo In Children
Abstract
One of the most distressing and difficult problems we encounter in the clinical setting is vitiligo in children and adolescents. In this symposium, several clinicians, some with a special interest in vitiligo, detail their approach to the treatment of this disorder in the pediatric age group.
Nancy Burton Esterly, M.D.
REFERENCES
- 1 Grimes PE, Kenney JAJr, Should vitiligo be treated Cutis 1983; 32: 343–345.
- 2 Porter J, Beuf AH, Nordlund JJ, et al. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73.
- 3 Grimes PE, Minus HR, Chakrabarti SG, et al. Determination of optimal topical photochemotherapy for vitiligo, J Am Acad Dermatol 1982; 7: 771–778.
- 4 Kenney JA Jr, Grimes PE. How we treat vitiligo, Cutis 1983; 32: 347–348.
- 5 Stern RS, Parrish JA, Eitzpatrick TB, Ocular findings in patients treated with PUVA. J Invest Dermatol 1985; 85: 269–273.
- 1 Bickers DR. Position paper — PUVA therapy. J Am Acad Dermatol 1983; 8: 265.
- 2 Harber LC, Bickers DR. Photosensitivity Diseases. Philadelphia : WB Saunders, 1981; 45–52.
- 3 Mosher DR, Pardsh JA, Fitzpatrick TB. Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol 1977; 97: 669.
- 4 Porter J, Beuf A, Nordlund JJ, et al. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73.
- 1 Hertz KA. Autoimmune vitiligo. N Engl J Med 1977; 297: 634–637.
- 2 Fulton JE, Leyden JE, Papa C. Treatment of vitiligo with topical methoxsalen and blacklight. Arch Der-matol 1969; 100: 224–229.
- 3 Parrish JA, Eitzpatrick TB, Shea C, et al. Photo-chemotherapy of vitiligo. Arch Dermatol 1976; 112: 1531–1534.
- 4 Stern RS, Thibodeau LA, Kleinerman RA, et al. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 809–813.
- 5 Freeman RG, Troll D. Photosensitization of the eye by 8-methoxypsoralen. J Invest Dermatol 1969; 53: 449–453.
- 1 Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important? JAMA 1978; 239: 1183–1187.
- 2 Albert SM, Nordlund JJ, Lerner AB. Ocular abnormalities occurring with vitiligo. Ophthalmology 1979; 86: 1145–1158.
- 3 Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo. Arch Dermatol 1976; 112: 1531–1534.
- 1 Nordlund J, Lerner A. Vitiligo. It is important. Arch Dermatol 1982; 118: 5–8.
- 2 Falabella R. Repigmentation of segmental vitiligo by autologous minigrafting. J Am Acad Dermatol 1983; 9: 514–521,.
- 3 Tsuji T, Hamada T. Topically administered fluorouracil in vitiligo. Arch Dermatol 1983; 119: 722–727.
- 4 Kumari J. Vitiligo treated with topical clobetasol pro-pionate. Arch Dermatol 1984; 120: 631–635.
- 5 Grimes P, et al. Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 1982; 7: 771–778.
- 6 Minus HR, Chokrabarti SG. Current status of oral PUVA therapy for psoriasis. J Am Acad Dermatol 1979; 1: 106–119.
- 7 Kenney J. Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation. Arch Dermatol 1971; 103: 475–480.
- 1 Kenney JA Jr, Grimes PE. How we treat vitiligo. Cutis 1983; 32: 347–348.
- 1 Hill-Beuf A, Porter JD. Children coping with impaired appearance: social and psychologic influences. Gen Hosp Psychiatry 1984; 6: 294–301.
- 2 Kenney JAJr, Grimes PE. How we treat vitiligo. Cutis 1983; 32: 347–348.
- 3 Grimes PE, Kenney JA Jr. Should vitiligo be treated Cutis 1983; 32: 343–344.
- 4 Lerner AB, Nordlund JJ. Vitiligo. What is it Is it important? JAMA 1978; 239: 1183–1187.
- 5 Klaus S, Lerner AB, Vitiligo J Am Acad Dermatol 1984; 11: 997–1000.